Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

Altimmune, Inc.

NASDAQ: ALTHealthcare / Biotechnology / -
2.74-0.0800-2.84%Vol 650 6861Y Perf -88.25%
Apr 18th, 2019 16:00
BID2.70 ASK2.73
Open2.80 Previous Close2.82
Pre-Market- After-Trading-
 - -%  - -%
Target Price
10.00 
Analyst Rating
Strong Buy 1.00
Potencial %
269.00 
Finscreener Ranking
★★★★★ —    -
Insiders Trans % 3/6/12M
-/-/100 
Value Ranking
★★★+ —    -
Insiders Value % 3/6/12M
-/-/100 
Growth Ranking
★★★★     59.17
Insiders Shares Cnt. % 3/6/12M
-/-/100 
Income Ranking
 —    -
Market Cap (mil)25 
Earnings Rating
Neutral
Price Range Ratio 52wk %
3.01 
Earnings Date
21st May 2019

Today's Price Range

2.652.84

 

52wk Range

1.7036.25

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Month
-2.42%
3 Months
-3.09%
6 Months
-32.05%
1 Year
-88.25%
3 Years
-96.57%
5 Years
-94.40%

Name / TickerPriceChg.Chg.%
ALT2.74-0.0800-2.84
AAPL203.860.73000.36
GOOG1 236.370.03000.00
MSFT123.371.60001.31
XOM81.13-0.3000-0.37
WFC47.580.03000.06
JNJ137.52-1.0000-0.72
FB178.28-0.5000-0.28
GE9.350.23002.52
JPM113.46-0.8400-0.73
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio
8.40
Current Ratio
8.70
Long Term Debt to Total Capital
0.01
Total Debt to Equity
0.01
Interest Coverage
-151.50
Leverage Ratio 1.30
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin
-
EBIT Margin
-435.80
EBITDA Margin
-432.90
Pre-tax Profit Margin
450.00
Profit Margin
-
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)
7 640
Revenue per Share
0.57
Revenue Growth 3 Years
37.81
Revenue Growth 5 Years
-6.47

Earnings HistoryEstimateReportedSurprise %
Q03 2018-3.60-1.7351.94
Q02 2018-4.50-4.80-6.67
Q01 2018-15.02-6.9153.99
Q04 2017-15.02-3.6076.03
Q03 2017-6.91-10.21-47.76
Q04 2016-11.80-
Q02 2016-1.20-
Q01 2016--0.02-
Earnings Per EndEstimateRevision %Trend
12/2018 QR-2.800.00-
12/2018 QR-2.8037.78Positive
12/2018 FY-21.870.00-
12/2019 FY-2.060.00-
Next Report Date21st May 2019
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume650 686
Shares Outstanding (in ths.)9 078
Trades Count2 087
Dollar Volume1 709 623
Avg. Volume1 462 935
Avg. Weekly Volume858 986
Avg. Monthly Volume921 166
Avg. Quarterly Volume1 667 750

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

50%50%

Bearish Bullish

39%61%

Bearish Bullish

33%67%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
1 (100.00 %)
1 (100.00 %)
1 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

There are no comments yet.

News